On May 23, 2023, Rain Oncology Inc. (NASDAQ: RAIN) opened at $1.25, higher 1.64% from the last session. During the day, the shares moved up to $1.36 and dropped to $1.16 before settling in for the closing price of $1.22. Price fluctuations for RAIN have ranged from $1.11 to $14.48 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -2.20% at the time writing. With a float of $14.90 million, this company’s outstanding shares have now reached $36.34 million.
Let’s determine the extent of company efficiency that accounts for 63 employees.
Rain Oncology Inc. (RAIN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Rain Oncology Inc. is 6.00%, while institutional ownership is 61.80%. The most recent insider transaction that took place on Nov 22, was worth 636,790. In this transaction Director of this company bought 77,000 shares at a rate of $8.27, taking the stock ownership to the 1,005,207 shares. Before that another transaction happened on Nov 21, when Company’s Director bought 45,000 for $7.80, making the entire transaction worth $351,000. This insider now owns 928,207 shares in total.
Rain Oncology Inc. (RAIN) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 3/30/2023, the company posted -$0.56 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.61) by $0.05. This company achieved a return on equity of -62.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.20% per share during the next fiscal year.
Rain Oncology Inc. (NASDAQ: RAIN) Trading Performance Indicators
Check out the current performance indicators for Rain Oncology Inc. (RAIN). In the past quarter, the stock posted a quick ratio of 5.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.61, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -1.98 in one year’s time.
Technical Analysis of Rain Oncology Inc. (RAIN)
Looking closely at Rain Oncology Inc. (NASDAQ: RAIN), its last 5-days average volume was 8.75 million, which is a jump from its year-to-date volume of 0.67 million. As of the previous 9 days, the stock’s Stochastic %D was 24.75%. Additionally, its Average True Range was 1.17.
During the past 100 days, Rain Oncology Inc.’s (RAIN) raw stochastic average was set at 0.97%, which indicates a significant decrease from 1.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 860.32% in the past 14 days, which was higher than the 342.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.9088, while its 200-day Moving Average is $7.4787. However, in the short run, Rain Oncology Inc.’s stock first resistance to watch stands at $1.3467. Second resistance stands at $1.4533. The third major resistance level sits at $1.5467. If the price goes on to break the first support level at $1.1467, it is likely to go to the next support level at $1.0533. Now, if the price goes above the second support level, the third support stands at $0.9467.
Rain Oncology Inc. (NASDAQ: RAIN) Key Stats
There are currently 36,363K shares outstanding in the company with a market cap of 44.32 million. Presently, the company’s annual sales total 0 K according to its annual income of -75,720 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -20,480 K.
